1. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
by Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai, Catherine Fitzgerald, Karamjit Gill, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier, Judy Sutherland, Randy D. Gascoyne, and Joseph M. Connors
Blood
Volume 109(5):
March 1, 2007
©2007 by American Society of Hematology

2. Overall outcome.
Overall outcome. Progression-free survival (A) and overall survival (B) in 365 patients with DLBCL treated with R-CHOP in British Columbia.
Laurie H. Sehn et al. Blood 2007;109:
©2007 by American Society of Hematology

3. Outcome according to the standard International Prognostic Index (IPI).
Outcome according to the standard International Prognostic Index (IPI). Progression-free survival (A) and overall survival (B) according to the standard IPI.
Laurie H. Sehn et al. Blood 2007;109:
©2007 by American Society of Hematology

4. Outcome according to the number of International Prognostic Index (IPI) factors.
Outcome according to the number of International Prognostic Index (IPI) factors. Progression-free survival according to the number of IPI factors present at diagnosis.
Laurie H. Sehn et al. Blood 2007;109:
©2007 by American Society of Hematology

5. Outcome according to the revised International Prognostic Index (R-IPI).
Outcome according to the revised International Prognostic Index (R-IPI). Progression-free survival (A) and overall survival (B) according to the R-IPI.
Laurie H. Sehn et al. Blood 2007;109:
©2007 by American Society of Hematology